News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Regulatory
Innate Pharma (IPH.PA ) : DSMB Recommends Continuation Of Effikir Trial With Two Arms 3/30/2015
Onyx Scientific Limited Release: CRO To Expand GMP Capability 3/30/2015
European Medicines Agency Release: Gardasil 9 Offers Wider Protection Against Cancers Caused By Human Papillomavirus (HPV) 3/27/2015
TransUnion Approved By SAFE-BioPharma, LLC Trust Framework 3/25/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Status From The European Medicines Agency For Ovarian Cancer 3/25/2015
Faster FDA Means More Cancer Breakthroughs 3/24/2015
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion On Application For Orphan Designation By The European Medicines Agency Agency For Ampligen To Treat Patients With Ebola Virus Disease (EVD) 3/24/2015
Kemwell Announces Successful FDA Inspection 3/24/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
InMed Receives Exemption Status From Health Canada 3/23/2015
Pfenex (PFNX) Announces Early HSR Clearance For Collaboration With Hospira 3/23/2015
THERAVECTYS Granted Authorization By The French National Agency For Medicines To Produce Lentiviral Vectors For Clinical Use And CAR-T Cell Therapies Under GMP Standards 3/23/2015
Mesoblast Limited (MSB.AX) Selected For Fast Track Access To Potential Investment Incentives In Japan 3/19/2015
Opko Health, Inc. (OPK) Receives Accreditation From College of American Pathologists 3/18/2015
NYU Langone Medical Center Release: Quality Measures Approved For Childhood Sleep Apnea 3/16/2015
WIRB-Copernicus Group Release: Western Institutional Review Board Receives ISO 9001:2008 Certification 3/16/2015
FDA Rates Kitabis Pak As Therapeutic Equivalent Of TOBI 3/16/2015
MedSource National Completes SOC 2 Type II Audit With No Exceptions 3/10/2015
FDA Wants AcelRx (ACRX) to Run Another Trial on Zalviso Drug-Device Combo 3/10/2015
EXCLUSIVE: Experimental Cancer Drug From Oncoceutics Could Be Fast-Tracked, Says Exec 3/6/2015
Axsome Therapeutics Announces FDA Fast Track Designation For AXS-02 For The Treatment Of Pain Associated With Complex Regional Pain Syndrome 3/5/2015
Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Eli Lilly (LLY) For Development As A Personalized Medicine 3/3/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
TherapeuticsMD, Inc.  (TXMD) Has "Multiple Catalysts" in 2015/16 As Products Develop, Says Cowen and Company 2/26/2015
Federal Trade Commission Cracks Down on Marketers of "Melanoma Detection" Apps 2/24/2015
Medicago, Inc. Awarded A Contract By The U.S. Department Of Health And Human Services To Explore Alternate Production Methods For Ebola Antibodies 2/24/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
Vexim Announces Successful GMP Inspection by Brazil's National Health Surveillance Agency 2/19/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Pancreatic Cancer 2/17/2015
Siegfried Announces Comprehensive Solution For The Hameln Facility’s Regulatory Issues 2/16/2015
Emergent BioSolutions (EBS) Announces Primary Endpoints Met In Pivotal Study Supporting Licensure Of Building 55 2/13/2015
Contract Research Organization WCCT Global Certifies Laboratory Staff In Peripheral Blood Mononuclear Cell (PBMC) Isolation 2/12/2015
NanoSmart Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation For ANA-Conjugated Liposomal Doxorubicin For The Treatment Of Ewing's Sarcomaf 2/11/2015
T-Bird Pharma Inc. Announces License Renewal From Health Canada 2/10/2015
Symphony Clinical Research Gains Women’s Business Enterprise Certification 2/10/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For High Grade Gliomas In Pediatric Patients 2/9/2015
Solentim Awarded Quality Management System (QMS) Certification - ISO 9001:2008 2/9/2015
CASI Pharmaceuticals  (CASI) Announces Receipt Of Final Minutes From FDA Meeting Regarding Clinical And Regulatory Path Of ENMD-2076 For The Treatment Of Patients With Fibrolamellar Carcinoma (FLC) 2/9/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
FDA Snatches Back Breakthrough Status for Merck & Co. (MRK) Hepatitis C Drugs 2/5/2015
Aesica Secures Continuing FDA Approval Of Its Bulk Manufacture And Packaging Sites In Germany 2/2/2015
Rock Creek Pharmaceuticals Receives Clinical Trial Application Approval 1/30/2015
Opko Health, Inc. (OPK) And Pfizer (PFE) Receive Regulatory Clearance For Global Agreement 1/29/2015
Averica Announces Approved DEA Registration To Research Schedule I Controlled Substances 1/28/2015
Octapharma USA, Inc. Announces FDA Approval For 2nd Octagam® 10% Manufacturing Site, Expanding Product Availability 1/26/2015
Tianyin Pharmaceutical Co, Inc.'s JCM Updates On Import Registration For International Clients 1/26/2015
Neuland Labs Reports Another Successful FDA Audit And Wins 2015 CMO Leadership Award 1/26/2015
Frequentz Simplifies GS1 Compliance For Pharmaceutical Supply Chain To Meet FDA Drug Supply Chain Security Act Extended Deadline 1/22/2015
Prosolia, Inc. Expands Capacity And Achieves ISO 9001:2008 Quality Management System Certification 1/22/2015
NeoStem, Inc. Receives Drug Manufacture License For Irvine Facility 1/20/2015
Tianyin Pharmaceutical Co, Inc. QLF Received GMP Certification 1/20/2015
Mylan Inc. (MYL) Release: U.S. Supreme Court Partially Modifies Standard Of Review Of Patent Claim Construction And Remands Review Of Teva's '808 Patent On Copaxone® To Federal Circuit Court Of Appeals 1/20/2015
Ariad Pharmaceuticals, Inc. (ARIA) Announces Final Decision From European Commission Endorsing Iclusig’s Approved Indications Throughout Europe 1/20/2015
United States Department Of Agriculture (USDA) Deregulates Monsanto Company (MON)’s Next-Generation Weed Control Trait Technology 1/16/2015
Veloxis Pharmaceuticals A/S (VELO) Confirms Receipt Of U.S. FDA Administration Decision 1/13/2015
Axxess Pharma, Inc. Receives Approval By Major Canadian Distributor To Sell TapouT Products To Over 2,000 Independent Pharmacies 1/13/2015
Achaogen (AKAO) Announces Plazomicin Granted QIDP Designation By FDA 1/8/2015
Epic Sciences Receives CLIA Certification For Its Cancer Diagnostics Laboratory 1/8/2015
TPI QLF To Receive GMP Certification 1/8/2015
Tauriga Sciences Inc. (TAUG) Confirms That Canadian Trading Halt (Cease Trade) Has Been Lifted By Autorite Des Marches Financiers (Quebec Based Regulatory Authority) 1/8/2015
Aratana Therapeutics (PETX) Granted Full License For AT-004 By United States Department Of Agriculture (USDA) 1/6/2015
Buchang Pharma Visits Tianyin Pharmaceutical Co, Inc. Qionglai Facility 1/6/2015
Tianyin Pharmaceutical Co, Inc. QLF Achieved Public Notice Status Of GMP Certification 12/24/2014
Acquisition Of Sigma-Aldrich Corporation (SIAL) By Merck KGaA (MKGAF.PK), Darmstadt, Germany, Receives U.S. Antitrust Clearance 12/23/2014
China Biologic Products Receives GMP Certification For New Coagulation Factor Facility 12/23/2014
Successful FDA Inspection At Hovione 12/18/2014
EXCLUSIVE: Sanofi Pasteur (SASY.PA) US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax 12/18/2014
Marrone Bio Innovations, Inc' REGALIA® MAXX Biofungicide Receives Registration In Brazil 12/17/2014
ImmunID Receives Authorization to Start Its PREDICT-ID Clinical Trial in Metastatic Melanoma Patients Treated With an Immune Checkpoint Inhibitor 12/10/2014
Vigilant Biosciences, Inc. Marks Significant Milestone With ISO 13485:2003 Certification 12/10/2014
Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam 12/8/2014
NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Earns AABB Re-Accreditation For Its Allendale, NJ Manufacturing Facility 12/8/2014
Metamark Laboratory Received Accreditation From College of American Pathologists 12/8/2014
Sanofi (SAN.PA) Chairman Says French Tax Burden Is Hindering Hunt For New CEO 12/8/2014
IntelGenx Corp. Grants Extension Of Marketing Exclusivity In The U.S. To Edgemont Pharmaceuticals, LLC. Of Forfivo XL(R) 12/5/2014
Fifteen Indians Blinded After Surgery With Suspected Infected Tools 12/5/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
Cellectar Biosciences  (NVLT) Granted Orphan Designation For I-131-CLR1404 For The Treatment Of Multiple Myeloma 12/5/2014
GVK Biosciences Review: Some Member States Suspend Marketing Authorisations For Concerned Medicines 12/5/2014
ChemoCentryx, Inc. (CCXI) Granted EU Orphan Drug Designation For CCX168, An Orally Administered Complement C5a Receptor Inhibitor, For The Treatment Of Microscopic Polyangiitis And Granulomatosis With Polyangiitis, Two Forms Of ANCA-Associated Vasculitis 12/4/2014
CytRx Corporation (CYTR) Receives Written FDA Communication Regarding Partial Clinical Hold For Aldoxorubicin Clinical Trials 12/4/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
Venaxis, Inc. (APPY) Files Response To FDA's Request For Additional Information 12/4/2014
CorMedix (CRMD) Files Request With FDA For QIDP Designation For Neutrolin 12/4/2014
Maharashtra FDA Executes "Surprise Inspection Spree" On Hundreds Of Pharma Units 12/3/2014
Germany Bars Antibiotic Cephalosporin From Ranbaxy Laboratories (RANBAXY.BO)'s Madhya Pradesh Plant 12/3/2014
Rhinomed Mute Granted US FDA Registration 12/3/2014
Novartis AG (NVS)' Heart Failure Medicine LCZ696 Granted Accelerated Assessment By CHMP In Europe 12/2/2014
Relmada Therapeutics Receives Health Canada Clearance To Commence First Clinical Study Of D-Methadone 12/2/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For Pancreatic And Ovarian Cancers 12/2/2014
Inventiva Receives Another Positive Opinion On Orphan Drug Designation In The European Union For IVA337 – For Idiopathic Pulmonary Fibrosis 12/2/2014
Ignyta (RXDX) Announces CLIA Certification Achieved By Its Diagnostic Laboratory 12/2/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback From European Medicines Agency On Advancing ICT-107 To Phase 3 Program 12/1/2014
SureClinical Wins FDA Part 11 And EC Annex 11 Compliance Validation 12/1/2014
FDA Priority Review Voucher Scheme Under Fire 11/26/2014
Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation From European Medicines Agency 11/24/2014
Beximco Pharmaceuticals Becomes First Bangladeshi Company To Receive GMP Approval From Health Canada 11/24/2014
FDA Grants QIDP Designation To Bayer AG (BAYZF)'s Amikacin Inhale And Ciprofloxacin Dry Powder For Inhalation 11/24/2014
Yabao Pharmaceuticals In-licenses China Rights To Parkinson's Drug Technology 11/21/2014
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG (NVS)'s Xolair To Treat Chronic Hives 11/20/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Terumo BCT And Banco de Sangre de Servicios Mutuos Unite In A Treatment Use Program Developed To Help Improve Blood Supply Safety Using An Investigational Device 11/19/2014
FDA Puts Partial Hold On CytRx Corporation (CYTR)'s Aldoxorubicin Clinical Trials 11/19/2014
FDA Delays Final Rule On Allowing Generic Drug Makers To Update Labels 11/18/2014
TissueGene, Inc. Receives Recommendations From FDA On Pathway To Phase 3 Trial Of TG-C For Treatment Of Osteoarthritis Of The Knee 11/17/2014
Cell Source's Megadose Drug Combination Receives Regulatory Approval In Italy To Commence Human Clinical Trials 11/13/2014
Polyphor’s Lead Antibiotic POL7080 Receives Qualified Infectious Disease Product (QIDP) Designation From The FDA 11/12/2014
U.S. FDA Sends Warning Letter To Cadila Pharmaceuticals 11/12/2014
AcelRx Pharmaceuticals (ACRX) Receives International Standards Organization (ISO) 13485:2003 Certification Of Its Quality Management System 11/10/2014
Cardiome Pharma Corp. (COM.TO) Submits BRINAVESS® Reimbursement Dossier To Italian Authorities To Support Market Access 11/10/2014
Mabion: Consultation On FDA Certification 11/5/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
Lannett Company, Inc. (LCI) Announces Positive FDA Inspection Results 11/3/2014
Veloxis Pharmaceuticals A/S (VELO) Announces Tentative Approval Of Envarsus® XR 10/31/2014
RetroSense Therapeutics Granted Orphan Drug Designation For Lead Product RST-001 For Retinitis Pigmentosa 10/30/2014
IntelliPharmaCeutics Reports That The FDA Has Given Its Toronto Manufacturing Facility An "Acceptable" Classification 10/27/2014
Tianyin Pharmaceutical Co, Inc.'s QLF Updates On Its GMP Certification Progress 10/23/2014
Clanotech AB Receives Orphan Drug Designation In The EU 10/20/2014
U.S. Regulators Ask Three Labs For Mapp Biopharmaceutical's ZMapp Ebola Plans 10/20/2014
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Harvoni™ (ledipasvir/sofosbuvir), The First Once-Daily Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C 10/17/2014
China Biologic Products Receives Approval For Commercial Manufacturing Of Human Prothrombin Complex Concentrate At Shandong Taibang Facility 10/17/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
Nuvilex (NVLX) Applies To FDA For Orphan Drug Designation For Its Cell-In-A-Box® Treatment For Pancreatic Cancer 10/13/2014
Amgen (AMGN)'s Leukemia Drug Blinatumomab Gets FDA Priority Review 10/10/2014
Shire Pharmaceuticals Group plc (SHPGY) Provides Regulatory Update On SHP 465, Investigational Compound For ADHD In Adults 10/9/2014
Abattis Announces Zoning Approval On The Experion MMPR Application 10/8/2014
Manzo Pharmaceuticals Gets Confirmation That Lacto-Freedom Probiotic Is A Dietary Supplement And Will Not Need FDA Approval 10/7/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
FDA Grants Durata Therapeutics, Inc.  (DRTX) A Special Protocol Agreement (SPA) For Its Phase 3 Study Of DALVANCE(TM) In Hospitalized Community-Acquired Pneumonia 10/3/2014
Merck & Co. (MRK) Congratulates Ecuador As Second Country To Receive Pan American Health Organization/World Health Organization Verification Of Elimination Of River Blindness 10/3/2014
Rare Cancers Europe Calls For New Criteria To Be Used In Clinical Trials On Rare Cancer Treatments 10/2/2014
Information Update - Health Canada Takes Action To Stop Import Of Products From Three Sites In India 10/1/2014
Valeant Pharmaceuticals International (VRX)' Bridgewater Location Receives Warning Letter From FDA 9/30/2014
U.S. Patent and Trademark Office Issues Can-Fite BioPharma (CFBI) Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/30/2014
Tianyin Pharmaceutical Co, Inc.'s QLF Completes GMP Site Inspection By CFDA 9/29/2014
AcelRx Pharmaceuticals (ACRX) Provides Regulatory Update On Zalviso™ 9/26/2014
Information Update - Health Canada Requests Quarantine Of Products For Canadian Market From Apotex Inc. Facility In Bangalore, India 9/25/2014
Emergency Use Of Tekmira Pharmaceuticals Corporation (TKMR)'s Ebola Drug Cleared By FDA, Health Canada 9/24/2014
Anti-Addiction Groups Call For FDA Commissioner To Step Down 9/24/2014
IMRIS Announces Waiver And Amendment Agreement And Repricing Of Warrants 9/24/2014
Medunik Canada Announces Health Canada Priority Review Of PHEBURANE® Indicated For The Treatment Of Urea Cycle Disorders (UCD) 9/24/2014
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014
KemPharm, Inc. Receives Health Canada Approval To Begin KP201 Clinical Trials In Canada 9/23/2014
Parenteral Drug Association Launches Effort To Harmonize Global Post-Approval Changes Protocols 9/22/2014
Natco Pharma Limited, Orchid Chemicals Hit With A Strong Dose Of FDA Medicine 9/19/2014
GlaxoSmithKline (GSK) Resolves Violation Issue At Montana Facility 9/18/2014
Spectrum Pharmaceuticals, Inc. (SPPI) Out-Licenses Rights For Greater China To CASI Pharmaceuticals  (ENMD) For Three Of Its Drugs 9/18/2014
Seward Secures Strong Environmental Credentials Through ISO14001 Certification 9/18/2014
Thermo Fisher Scientific (TMO) Announces Listing Of The Ion PGM Dx System With The U.S. FDA As Class II Medical Device 9/18/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback On ICT-107 Supporting Advancement To Registrational Phase 3 Testing In Newly Diagnosed Glioblastoma 9/17/2014
Soligenix (SNGX) Announces FDA Clearance Of Phase 3 Clinical Protocol Of SGX301 In Cutaneous T-Cell Lymphoma 9/17/2014
Acura Pharmaceuticals, Inc. (ACUR) Submits Formal Dispute Resolution Request With FDA Regarding Hydrocodone Bitartrate With Acetaminophen Tablets 9/17/2014
FDA Panel Backs Limits On Testosterone Drugs 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Alchem International Commits To Tropane Alkaloid Apis And Extends Production And Regulatory Support To Resolve Supply Gap 9/15/2014
FDA's Surprise Visit To Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)'s Pressures Stock 9/12/2014
Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 9/12/2014
Tianyin Pharmaceutical Co, Inc. Release: JCM Applies For Azithromycin API Import Certificate At India 9/9/2014
Columbia Laboratories, Inc. (CBRX) Announces Completion Of CRINONE License Renewal 9/8/2014
Cleveland Biolabs Inc. (CBLI) Announces Green Light To Submit Pre-Emergency Use Authorization Application For Entolimod 9/4/2014
Ex-Researcher From Now-Dissolved Cetero Rebukes FDA Over Warning Letter 9/4/2014
Ganeden Biotech Release: USP Issues Testing Standards Monograph For GanedenBC30. 9/3/2014
Cleveland Biolabs Inc. (CBLI) To Report Outcome Of July FDA Meeting And Host Conference Call On September 3 9/3/2014
Ajinomoto Althea, Inc. Receives European GMP Certification 9/3/2014
U.S. FDA Grants QIDP Status For Wockhardt (WOCKHARDT.BO) Anti-Infective Drug Discovery Program 9/2/2014
Tianyin Pharmaceutical Co, Inc. Submits Dataset For GMP Inspection At Qionglai Facility (QLF) 8/29/2014
FDA Chastises Alexion Pharmaceuticals Inc. (ALXN) For Production Problems Again 8/28/2014
m2p-labs' Environmental Management System Successfully Certified 8/27/2014
Cesca Therapeutics Advocates Benefits Of Cell Therapy To The Centers for Medicare & Medicaid Services 8/27/2014
Apotex Inc. Release: NAFTA Tribunal Decision Supports FDA And Its Actions 8/26/2014
CEN Biotech Announces The Completion Of Its Pre-License Inspection By Health Canada 8/26/2014
FDA Finds Falsified Data, Serious Mold, And Decaying Frogs At Amanta (Formerly Known As Marck Biosciences) 8/21/2014
SANAFOR™ Antimicrobial Technology For Plastics, From Janssen PMP, Receives U.S. EPA Registration 8/21/2014
Exco Intouch Achieves Quality Milestone With Iso9001:2008 Certification 8/21/2014
WuXi PharmaTech Co., Ltd. Facility Passes FDA Inspection For Manufacture Of API 8/18/2014
CVS Caremark Corporation (CVS)'s Accordant Health Services Receives NCQA Disease Management Accreditation 8/18/2014
Tianyin Pharmaceutical Co, Inc. Release: Qionglai Facility (QLF) Schedules September For GMP Examination 8/18/2014
FDA Advisory Committee Recommends Approval Of Tiotropium Respimat® For The Maintenance Treatment Of COPD 8/15/2014
Brunswick Labs Certification Program 2014 Q2 Activity Report 8/14/2014
Popular Toothpaste Contains Cancer-Causing Ingredient 8/13/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
Easton Pharmaceuticals (OP: EAPH) Announces Medical Marijuana Site Facility Visit And Inspection 8/12/2014
ZAI Lab Of Shanghai In-Licenses Two Respiratory Drugs From Sanofi 8/12/2014
Androgen Study Group Urges Investigation Into Ethical Violations By JAMA Regarding Controversial Testosterone Study 8/11/2014
Advanced Cell Diagnostics, Inc. Receives ISO 13485:2003 Certification 8/11/2014
Cardiome Pharma Corp. (COM.TO) Submits BRINAVESS Dossier To French Authorities To Support Market Access 8/7/2014
MD Anderson Cancer Center Postdoc Faked Results Of Novartis AG (NVS) Brain Tumor Study 8/7/2014
FDA Will Regulate Thousands Of Cancer, Genetic, And Other Diagnostic 8/5/2014
Raptor Pharmaceutical Inc. (RPTP) Receives Orphan Drug Designation For Cysteamine Bitartrate In Huntington's Disease From The European Commission 8/4/2014
ibidi Awarded With Seal Of Quality 8/4/2014
ATS Labs Release: EPA Approves Protocols For Antimicrobial Fogging & Misting Application Claims 8/4/2014
IMPAX Laboratories, Inc. (IPXL)'s Hayward Facility Continues To Disappoint The FDA 8/4/2014
Rock Creek Pharmaceuticals Provides Update Of Its European Drug Development Regulatory Strategy And Selects Quotient Clinical For Its Early Development Programs 8/1/2014
FDA Concern Over Drug Production Process At India's Cadila 7/31/2014
Israel's Ministry Of Health Approves Pluristem Therapeutics (PSTI)'s Commercial-Scale 3D Cell Manufacturing Process Used At Its New Haifa Facility 7/31/2014
Successful FDA Inspection At Hovione's API Manufacturing Plant In Cork, Ireland 7/31/2014
IMPAX Laboratories, Inc. (IPXL) Parkinson's Drug Future Shaky As FDA Cites Factory Issues 7/30/2014
Ampio Pharmaceuticals, Inc. (AMPE) Announces The FDA Has Issued A Written Response And Accepted The Ampio Plan For Beginning Production Of Ampion™ In The New Facility 7/30/2014
FDA Performs Inspection Of IMPAX Laboratories, Inc. (IPXL)'s Taiwan Facility 7/29/2014
Parnell Pharmaceuticals Holdings Acquires License For Intellectual Property And Rights To Develop Compounds For Bone And Dermal Regeneration 7/25/2014